Vivo Bio Tech Limited

BSE:511509 Stock Report

Market Cap: ₹701.4m

Vivo Bio Tech Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Alangudi Sankaranarayanan

Chief executive officer

₹750.0k

Total compensation

CEO salary percentage100.0%
CEO tenure3yrs
CEO ownershipn/a
Management average tenure3yrs
Board average tenure4.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Alangudi Sankaranarayanan's remuneration changed compared to Vivo Bio Tech's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2024n/an/a

₹70m

Sep 30 2024n/an/a

₹75m

Jun 30 2024n/an/a

₹26m

Mar 31 2024₹750k₹750k

₹25m

Dec 31 2023n/an/a

₹39m

Sep 30 2023n/an/a

₹27m

Jun 30 2023n/an/a

₹25m

Mar 31 2023₹2m₹2m

₹26m

Dec 31 2022n/an/a

-₹1m

Sep 30 2022n/an/a

₹11m

Jun 30 2022n/an/a

₹13m

Mar 31 2022₹1m₹287k

₹22m

Dec 31 2021n/an/a

₹32m

Sep 30 2021n/an/a

₹41m

Jun 30 2021n/an/a

₹59m

Mar 31 2021₹50kn/a

₹57m

Dec 31 2020n/an/a

₹50m

Sep 30 2020n/an/a

₹40m

Jun 30 2020n/an/a

₹42m

Mar 31 2020₹40kn/a

₹44m

Dec 31 2019n/an/a

₹19m

Sep 30 2019n/an/a

₹18m

Jun 30 2019n/an/a

₹15m

Mar 31 2019₹60kn/a

₹22m

Compensation vs Market: Alangudi's total compensation ($USD8.67K) is below average for companies of similar size in the Indian market ($USD41.58K).

Compensation vs Earnings: Alangudi's compensation has been consistent with company performance over the past year.

CEO

Alangudi Sankaranarayanan (81 yo)

3yrs

Tenure

₹750,000

Compensation

Dr. Alangudi Sankaranarayanan, M.V.Sc., Ph D., F.C.P., serves as CEO, President and Whole Time Director of Vivo Bio Tech Ltd. since January 6, 2022.He had been Non-Independent Non-Executive Director of Vi...

Leadership Team

NamePositionTenureCompensationOwnership
Alangudi Sankaranarayanan
CEO, President & Whole Time Director3yrs₹750.00kno data
Sri Kompella
Whole Time Director3.8yrs₹1.39mno data
Ayinampudi Kiran
Company Secretary & Compliance Officer2yrs₹178.00kno data
Kalyan Mangipudi
Whole Time Director3yrs₹861.20kno data
Viswanath Kompella
Founder & Advisorno datano data1.01%
₹ 7.1m
Chandrasekhar Patnaik
Chief Business Officer2yrsno datano data
Pinakin Soni
Head - Discovery Servicesno datano datano data
Kandula Srinivasa Rao
Head – Toxicologyno datano datano data

3.0yrs

Average Tenure

51yo

Average Age

Experienced Management: 511509's management team is considered experienced (3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Alangudi Sankaranarayanan
CEO, President & Whole Time Director15.5yrs₹750.00kno data
Sri Kompella
Whole Time Director3.2yrs₹1.39mno data
Kalyan Mangipudi
Whole Time Director15.2yrs₹861.20kno data
Kunda N. Reddy
Independent Chairman4.6yrsno datano data
Shivanand Karopadi
Non-Independent Non Executive Director & Member of Scientific Advisory Board3.8yrsno datano data
Shyam Tipparaju
Non-Executive Independent Director1.4yrsno datano data

4.2yrs

Average Tenure

56yo

Average Age

Experienced Board: 511509's board of directors are considered experienced (4.2 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/22 11:36
End of Day Share Price 2025/01/22 00:00
Earnings2024/12/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vivo Bio Tech Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution